Letrozole as primary medical therapy for locally advanced and large operable breast cancer

J M Dixon, C D Love, C O Bellamy, D A Cameron, R C Leonard, H Smith, W R Miller

Research output: Contribution to journalArticlepeer-review

Abstract

To investigate the efficacy of letrozole 2.5 mg and 10 mg used as primary neoadjuvant therapy for patients with locally advanced and large operable breast cancer.
Original languageEnglish
Pages (from-to)191-9
Number of pages9
JournalBreast cancer research and treatment
Volume66
Issue number3
DOIs
Publication statusPublished - Apr 2001

Keywords

  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents
  • Breast Neoplasms
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Mastectomy, Segmental
  • Middle Aged
  • Neoadjuvant Therapy
  • Nitriles
  • Postmenopause
  • Receptors, Estrogen
  • Treatment Outcome
  • Triazoles

Fingerprint Dive into the research topics of 'Letrozole as primary medical therapy for locally advanced and large operable breast cancer'. Together they form a unique fingerprint.

Cite this